United Therapeutics buy Royal Bank of Canada
Start price
07.07.26
/
50%
€493.50
Target price
07.07.27
€615.51
Performance (%)
0.00%
Price
07.07.26
€493.50
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada is currently unchanged from the start price. This prediction currently runs until 07.07.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| United Therapeutics | 0.00% |
| iShares Core DAX® | 4.367% |
| iShares Nasdaq 100 | -0.294% |
| iShares Nikkei 225® | -0.471% |
| iShares S&P 500 | 1.267% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (UTHR) had its price target raised by Royal Bank Of Canada from $701.00 to $704.00. They now have an "outperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€485.40
07.05.26
07.05.26
€596.27
07.05.27
07.05.27
1.67%
07.07.26
07.07.26
United Therapeutics
Start price
Target price
Perf. (%)
€426.90
26.02.26
26.02.26
€544.04
26.02.27
26.02.27
15.60%
07.07.26
07.07.26
United Therapeutics
Start price
Target price
Perf. (%)
€364.40
26.09.25
26.09.25
€487.63
26.09.26
26.09.26
35.43%
07.07.26
07.07.26

